glp 1 and prostate cancer Could GLP-1 medications help slow progression?⁣ ⁣ A new Cleveland Clinic study found those taking GLP-1s were less likely to develop stage IV disease in several cancer types, when compared to May Patients Receiving GLP-1 Agonists

- Dosage: 2 mg to 5 mg twice per week for the first 4-6 weeks (loading phase), followed by 2 mg once per week (maintenance phase)

Melatonin supplementation attenuates cuproptosis and ferroptosis in aging cumulus and granulosa cells: potential for improving IVF outcomes in advanced maternal age

BPC-157 angiogenic mechanism: Increases VEGF expression triggering endothelial cell proliferation, migration, and tube formation

doi:10.1161/JAHA.122.025252 Huang J, Qin S, Huang L, Tang Y, Ren H, Hu H

Drug Metabol Drug Interact 23:329350 [DOI] [PubMed] [Google Scholar] Benoist CC, Wright JW, Zhu M, Appleyard SM, Wayman GA, Harding JW